MCP-2056: SPECIALTY ENZYMES – A GLOBAL STRATEGIC BUSINESS REPORT

Global Specialty Enzymes Market to Exceed $4.4 Billion by 2012, According to New Report by Global Industry Analysts, Inc.

Propelled by high demand from pharmaceutical and diagnostics markets, specialty enzymes market has been witnessing high growth rates. Global specialty enzymes market is projected to exceed $4.4 billion by the year 2012.

San Jose, California (PRWEB), April 23, 2008 -- Enzymes are proteins with highly specialized catalytic functions produced by all living organisms. Enzymes play a major role in various aspects of life and are very important to the existence of life itself. Three fourth of the ‘bulk’ consumption of enzymes is accounted for the industries of food, starch processing and detergent. Specialty enzymes are used in a host of medical applications and diagnostics, including testing of food products.

Asia-Pacific represents the fastest growing market for specialty enzymes, recording a CAGR of over 9% over the period 2000-2010, as stated by Global Industry Analysts, Inc. Specialty enzymes market in the US is estimated at $1.1 billion. In terms of product segments, global specialty medical enzymes market is expected to grow at a compounded annual rate of nearly 8.25% over the period 2000-2010. In Europe, demand for specialty enzymes in pharmaceuticals & diagnostics is projected to be worth $1.0 billion in 2012.

Protein engineering, gene expression and such advanced technologies aid in selective screening, modification and manufacture of enzymes in large quantities. As such the enzyme market is undergoing a gradual transition from commodity based to proprietary based with specialty enzymes supporting novel applications, and gradually narrowing down the distinction between industrial and specialty enzymes. Many major companies involved in enzyme production are endeavoring through various avant-garde technologies to progress in this direction. Companies ranging from biotechnology to chemicals, and pharmaceuticals are actively researching in this direction.

The report titled “Specialty Enzymes: A Global Strategic Business Report” published by Global Industry Analysts, Inc., provides a review of end-use markets, product overview, product introductions/innovations, and recent industry activity. The study provides market analytics for the period 2000-2015, in value sales for United States, Canada, Japan, Europe, Asia-Pacific, Middle East and Latin America. Product segments discussed include Specialty Medical Enzymes, Polymerases, Nucleases and Other Enzymes. End-use segments discussed are Pharmaceuticals & Diagnostics and Research/Biotechnology.

Market participants include Advanced Enzymes Technologies, Amano Enzyme, Aureozyme, Biocon, Biozyme Laboratories, Danisco, Genencor, Kinetic Biosystems, Maxygen, Codexis, Novozymes, Seravac Biotech, Specialty Enzymes and Biochemicals and Verenium Corporation.

» Click here to view full details of the report

« Back